{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:11:45Z","timestamp":1759133505492,"version":"3.37.3"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Liver Journal"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The pandemic of COVID19 which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first described in China as an unexplained pneumonia transmitted by respiratory droplets. Gastrointestinal (GI) and liver injury associated with SARS-CoV-2 infection were reported as an early or sole disease manifestation, mainly outside China. The exact mechanism and incidence of GI and liver involvement are not well elucidated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main body<\/jats:title>\n                <jats:p>We conducted a PubMed search for all articles written in the English language about SARS-CoV-2 affecting the GI and liver. Following data extraction, 590 articles were selected. In addition to respiratory droplets, SARS-CoV-2 may reach the GI system through the fecal-oral route, saliva, and swallowing of nasopharyngeal fluids, while breastmilk and blood transmission were not implicated. Moreover, GI infection may act as a septic focus for viral persistence and transmission to the liver, appendix, and brain. In addition to the direct viral cytopathic effect, the mechanism of injury is multifactorial and is related to genetic and demographic variations. The most frequently reported GI symptoms are diarrhea, nausea, vomiting, abdominal pain, and bleeding. However, liver infection is generally discovered during laboratory testing or a post-mortem. Radiological imaging is the gold standard in diagnosing COVID-19 patients and contributes to understanding the mechanism of extra-thoracic involvement. Medications should be prescribed with caution, especially in chronic GI and liver patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>GI manifestations are common in COVID-19 patients. Special care should be paid for high-risk patients, older males, and those with background liver disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43066-021-00123-6","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T19:02:29Z","timestamp":1627758149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["SARS-CoV-2-associated gastrointestinal and liver diseases: what is known and what is needed to explore"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6483-5056","authenticated-orcid":false,"given":"Dina","family":"Sweed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Abdelsameea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esraa A.","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Moaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inas","family":"Moaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimaa","family":"Abdelsattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa","family":"Mosbeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein A.","family":"Elmahdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Sweed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,31]]},"reference":[{"issue":"13","key":"123_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z (2020) Early transmission din Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382(13):1199\u20131207. https:\/\/doi.org\/10.1056\/NEJMoa2001316","journal-title":"N Engl J Med"},{"issue":"10","key":"123_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","volume":"382","author":"ML Holshue","year":"2020","unstructured":"Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G, Cohn A, Fox L, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK, Washington State -nCo VCIT (2020) First case of 2019 novel coronavirus in the United States. N Engl J Med 382(10):929\u2013936. https:\/\/doi.org\/10.1056\/NEJMoa2001191","journal-title":"N Engl J Med"},{"issue":"1","key":"123_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41392-020-00373-7","volume":"5","author":"P Zhong","year":"2020","unstructured":"Zhong P, Xu J, Yang D, Shen Y, Wang L, Feng Y, Du C, Song Y, Wu C, Hu X, Sun Y (2020) COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduction and Targeted Therapy 5(1):256. https:\/\/doi.org\/10.1038\/s41392-020-00373-7","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"123_CR4","doi-asserted-by":"publisher","unstructured":"Pamplona J, Solano R, Soler C, Sabat M (2020) Epidemiological approximation of the enteric manifestation and possible fecal\u2013oral transmission in COVID-19: a preliminary systematic review. Eur J Gastroenterol Hepatol Publish Ahead of Print. https:\/\/doi.org\/10.1097\/MEG.0000000000001934","DOI":"10.1097\/MEG.0000000000001934"},{"issue":"4","key":"123_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/omi.12289","volume":"35","author":"Y Li","year":"2020","unstructured":"Li Y, Ren B, Peng X, Hu T, Li J, Gong T, Tang B, Xu X, Zhou X (2020) Saliva is a non-negligible factor in the spread of COVID-19. Mol Oral Microbiol 35(4):141\u2013145. https:\/\/doi.org\/10.1111\/omi.12289","journal-title":"Mol Oral Microbiol"},{"key":"123_CR6","doi-asserted-by":"publisher","first-page":"141364","DOI":"10.1016\/j.scitotenv.2020.141364","volume":"749","author":"DL Jones","year":"2020","unstructured":"Jones DL, Baluja MQ, Graham DW, Corbishley A, McDonald JE, Malham SK, Hillary LS, Connor TR, Gaze WH, Moura IB, Wilcox MH, Farkas K (2020) Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19. Sci Total Environ 749:141364 https:\/\/doi.org\/10.1016\/j.scitotenv.2020.141364","journal-title":"Sci Total Environ"},{"key":"123_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejim.2020.05.035","volume":"77","author":"P Portincasa","year":"2020","unstructured":"Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A (2020) Hepatic consequences of COVID-19 infection. Lapping or biting? Eur J Intern Med 77:18\u201324. https:\/\/doi.org\/10.1016\/j.ejim.2020.05.035","journal-title":"Eur J Intern Med"},{"issue":"8","key":"123_CR8","doi-asserted-by":"publisher","first-page":"rjaa245","DOI":"10.1093\/jscr\/rjaa245","volume":"2020","author":"S Ahmad","year":"2020","unstructured":"Ahmad S, Ahmed RN, Jani P, Ullah M, Aboulgheit H (2020) SARS-CoV-2 isolation from an appendix. J Surg Case Rep 2020(8):rjaa245. https:\/\/doi.org\/10.1093\/jscr\/rjaa245","journal-title":"J Surg Case Rep"},{"issue":"10239","key":"123_CR9","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/S0140-6736(20)31181-8","volume":"395","author":"R Gro\u00df","year":"2020","unstructured":"Gro\u00df R, Conzelmann C, M\u00fcller JA, Stenger S, Steinhart K, Kirchhoff F, M\u00fcnch J (2020) Detection of SARS-CoV-2 in human breastmilk. Lancet 395(10239):1757\u20131758. https:\/\/doi.org\/10.1016\/S0140-6736(20)31181-8","journal-title":"Lancet"},{"issue":"11","key":"123_CR10","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.jiph.2020.05.001","volume":"13","author":"HJ Cho","year":"2020","unstructured":"Cho HJ, Koo JW, Roh SK, Kim YK, Suh JS, Moon JH, Sohn SK, Baek DW (2020) COVID-19 transmission and blood transfusion: a case report. Journal of Infection and Public Health 13(11):1678\u20131679 https:\/\/doi.org\/10.1016\/j.jiph.2020.05.001","journal-title":"Journal of Infection and Public Health"},{"issue":"1","key":"123_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jcmgh.2020.08.005","volume":"11","author":"L Chen","year":"2021","unstructured":"Chen L, Marishta A, Ellison CE, Verzi MP (2021) Identification of transcription factors regulating SARS-CoV-2 entry genes in the intestine. Cell Mol Gastroenterol Hepatol 11(1):181\u2013184. https:\/\/doi.org\/10.1016\/j.jcmgh.2020.08.005","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"123_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fnana.2020.00037","volume":"14","author":"MF DosSantos","year":"2020","unstructured":"DosSantos MF, Devalle S, Aran V, Capra D, Roque NR, Coelho-Aguiar JM, TCLdSe S, Subilhaga JG, Pereira CM, D\u2019Andrea Meira I, Niemeyer Soares Filho P, Moura-Neto V (2020) Neuromechanisms of SARS-CoV-2: a review. Front Neuroanat 14:37. https:\/\/doi.org\/10.3389\/fnana.2020.00037","journal-title":"Front Neuroanat"},{"issue":"1","key":"123_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1470320309347788","volume":"11","author":"L F\u00e4ndriks","year":"2009","unstructured":"F\u00e4ndriks L (2009) The angiotensin II type 2 receptor and the gastrointestinal tract. J Renin-Angiotensin-Aldosterone Syst 11(1):43\u201348. https:\/\/doi.org\/10.1177\/1470320309347788","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"4","key":"123_CR14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1365-2036.2011.04971.x","volume":"35","author":"M Garg","year":"2012","unstructured":"Garg M, Angus PW, Burrell LM, Herath C, Gibson PR, Lubel JS (2012) Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tract. Aliment Pharmacol Ther 35(4):414\u2013428. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04971.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"123_CR15","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1161\/HYPERTENSIONAHA.120.15256","volume":"76","author":"M Davidson Anne","year":"2020","unstructured":"Davidson Anne M, Wysocki J, Batlle D (2020) Interaction of SARS-CoV-2 and other coronavirus with ACE (angiotensin-converting enzyme)-2 as their main receptor. Hypertension 76(5):1339\u20131349. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15256","journal-title":"Hypertension"},{"key":"123_CR16","doi-asserted-by":"publisher","first-page":"198103","DOI":"10.1016\/j.virusres.2020.198103","volume":"286","author":"S Ahlawat","year":"2020","unstructured":"Ahlawat S, Asha SKK (2020) Immunological co-ordination between gut and lungs in SARS-CoV-2 infection. Virus Res 286:198103\u2013198103. https:\/\/doi.org\/10.1016\/j.virusres.2020.198103","journal-title":"Virus Res"},{"issue":"4","key":"123_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11894-018-0619-8","volume":"20","author":"P Panchal","year":"2018","unstructured":"Panchal P, Budree S, Scheeler A, Medina G, Seng M, Wong WF, Eliott R, Mitchell T, Kassam Z, Allegretti JR, Osman M (2018) Scaling safe access to fecal microbiota transplantation: past, present, and future. Current Gastroenterology Reports 20(4):14. https:\/\/doi.org\/10.1007\/s11894-018-0619-8","journal-title":"Current Gastroenterology Reports"},{"issue":"1","key":"123_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s13054-020-03182-0","volume":"24","author":"E Price","year":"2020","unstructured":"Price E (2020) Could the severity of COVID-19 be increased by low gastric acidity? Crit Care 24(1):456. https:\/\/doi.org\/10.1186\/s13054-020-03182-0","journal-title":"Crit Care"},{"key":"123_CR19","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.3389\/fimmu.2020.02132","volume":"11","author":"V Castelli","year":"2020","unstructured":"Castelli V, Cimini A, Ferri C (2020) Cytokine storm in COVID-19: \u201cwhen you come out of the storm, you won't be the same person who walked in\u201d. Front Immunol 11:2132\u20132132. https:\/\/doi.org\/10.3389\/fimmu.2020.02132","journal-title":"Front Immunol"},{"key":"123_CR20","doi-asserted-by":"publisher","unstructured":"Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F, Carson G, Merson L, Lee J, Plotkin D, Sigfrid L, Halpin S, Jackson C, Gamble C, Horby PW, Nguyen-Van-Tam JS, Ho A, Russell CD, Dunning J, Openshaw PJ, Baillie JK, Semple MG, investigators IC (2020) Features of 20\u2009133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 369:m1985-m1985. doi:https:\/\/doi.org\/10.1136\/bmj.m1985","DOI":"10.1136\/bmj.m1985"},{"issue":"6","key":"123_CR21","doi-asserted-by":"publisher","first-page":"916","DOI":"10.14309\/ajg.0000000000000664","volume":"115","author":"C Han","year":"2020","unstructured":"Han C, Duan C, Zhang S, Spiegel B, Shi H, Wang W, Zhang L, Lin R, Liu J, Ding Z, Hou X (2020) Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes. Am J Gastroenterol 115(6):916\u2013923. https:\/\/doi.org\/10.14309\/ajg.0000000000000664","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"123_CR22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.clinre.2020.04.012","volume":"44","author":"H Wang","year":"2020","unstructured":"Wang H, Qiu P, Liu J, Wang F, Zhao Q (2020) The liver injury and gastrointestinal symptoms in patients with coronavirus disease 19: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 44(5):653\u2013661. https:\/\/doi.org\/10.1016\/j.clinre.2020.04.012","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"123_CR23","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/j.gastro.2020.05.001","volume":"159","author":"S Sultan","year":"2020","unstructured":"Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, Falck-Ytter Y, El-Serag HB, AGAIEa (2020) AGA Institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology 159(1):320\u2013334.e327. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.001","journal-title":"Gastroenterology"},{"issue":"3","key":"123_CR24","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1053\/j.gastro.2020.05.053","volume":"159","author":"DE Freedberg","year":"2020","unstructured":"Freedberg DE, Conigliaro J, Wang TC, Tracey KJ, Callahan MV, Abrams JA, Famotidine Research G (2020) Famotidine use is associated with improved clinical outcomes in hospitalized COVID-19 patients: a propensity score matched retrospective cohort study. Gastroenterology 159(3):1129\u20131131.e1123. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.053","journal-title":"Gastroenterology"},{"key":"123_CR25","doi-asserted-by":"publisher","unstructured":"Hunt RH, East JE, Lanas A, Malfertheiner P, Satsangi J, Scarpignato C, Webb GJ (2020) COVID-19 and gastrointestinal disease: implications for the gastroenterologist. Dig Dis. https:\/\/doi.org\/10.1159\/000512152","DOI":"10.1159\/000512152"},{"issue":"7","key":"123_CR26","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.cgh.2020.03.043","volume":"18","author":"S Luo","year":"2020","unstructured":"Luo S, Zhang X, Xu H (2020) Don\u2019t overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19). Clin Gastroenterol Hepatol 18(7):1636\u20131637. https:\/\/doi.org\/10.1016\/j.cgh.2020.03.043","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"123_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.gastro.2020.03.065","volume":"159","author":"KS Cheung","year":"2020","unstructured":"Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, Ng YY, Chu MY, Chung TWH, Tam AR, Yip CCY, Leung K-H, Fung AY-F, Zhang RR, Lin Y, Cheng HM, Zhang AJX, To KKW, Chan K-H, Yuen K-Y, Leung WK (2020) Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology 159(1):81\u201395. https:\/\/doi.org\/10.1053\/j.gastro.2020.03.065","journal-title":"Gastroenterology"},{"issue":"9","key":"123_CR28","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/apt.15731","volume":"51","author":"Y Tian","year":"2020","unstructured":"Tian Y, Rong L, Nian W, He Y (2020) Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther 51(9):843\u2013851. https:\/\/doi.org\/10.1111\/apt.15731","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"123_CR29","doi-asserted-by":"publisher","first-page":"2758.e2751","DOI":"10.1016\/j.ajem.2020.05.072","volume":"38","author":"KH Chan","year":"2020","unstructured":"Chan KH, Lim SL, Damati A, Maruboyina SP, Bondili L, Abu Hanoud A, Slim J (2020) Coronavirus disease 2019 (COVID-19) and ischemic colitis: an under-recognized complication. Am J Emerg Med 38(12):2758.e2751\u20132758.e2754. https:\/\/doi.org\/10.1016\/j.ajem.2020.05.072","journal-title":"Am J Emerg Med"},{"issue":"6","key":"123_CR30","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1053\/j.gastro.2020.08.044","volume":"159","author":"S Inamdar","year":"2020","unstructured":"Inamdar S, Benias PC, Liu Y, Sejpal DV, Satapathy SK, Trindade AJ (2020) Prevalence, risk factors, and outcomes of hospitalized patients with coronavirus disease 2019 presenting as acute pancreatitis. Gastroenterology 159(6):2226\u20132228.e2222 https:\/\/doi.org\/10.1053\/j.gastro.2020.08.044","journal-title":"Gastroenterology"},{"issue":"10","key":"123_CR31","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.dld.2020.04.034","volume":"52","author":"H Zhang","year":"2020","unstructured":"Zhang H, Liao Y-S, Gong J, Liu J, Xia X, Zhang H (2020) Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: a report of 164 cases. Dig Liver Dis 52(10):1076\u20131079. https:\/\/doi.org\/10.1016\/j.dld.2020.04.034","journal-title":"Dig Liver Dis"},{"issue":"4","key":"123_CR32","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang F-S (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8(4):420\u2013422. https:\/\/doi.org\/10.1016\/S2213-2600(20)30076-X","journal-title":"Lancet Respir Med"},{"issue":"2","key":"123_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/jgh.15166","volume":"36","author":"L Zhang","year":"2020","unstructured":"Zhang L, Han C, Zhang S, Duan C, Shang H, Bai T, Hou X (2020) Diarrhea and altered inflammatory cytokine pattern in severe coronavirus disease 2019: impact on disease course and in-hospital mortality. Journal of Gastroenterology and Hepatology n\/a (n\/a) 36(2):421\u2013429. https:\/\/doi.org\/10.1111\/jgh.15166","journal-title":"Journal of Gastroenterology and Hepatology n\/a (n\/a)"},{"issue":"1","key":"123_CR34","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.jinf.2020.08.042","volume":"82","author":"Y Yan","year":"2021","unstructured":"Yan Y, Jiang X, Wang X, Liu B, Ding H, Jiang M, Yang Z, Dai Y, Ding D, Yu H, Zhang S, Liu J, Sha M, Lui C, Qiu Y, Lu H, Hu Q (2021) CCL28 mucosal expression in SARS-CoV-2-infected patients with diarrhea in relation to disease severity. J Infect 82(1):e19\u2013e21. https:\/\/doi.org\/10.1016\/j.jinf.2020.08.042","journal-title":"J Infect"},{"issue":"8","key":"123_CR35","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1136\/gutjnl-2020-321388","volume":"69","author":"M Effenberger","year":"2020","unstructured":"Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M, Hilbe R, Seiwald S, Scholl-Buergi S, Fritsche G, Bellmann-Weiler R, Weiss G, M\u00fcller T, Adolph TE, Tilg H (2020) Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut 69(8):1543\u20131544. https:\/\/doi.org\/10.1136\/gutjnl-2020-321388","journal-title":"Gut"},{"key":"123_CR36","doi-asserted-by":"publisher","unstructured":"Aghemo A, Piovani D, Parigi TL, Brunetta E, Pugliese N, Vespa E, Omodei PD, Preatoni P, Lleo A, Repici A, Voza A, Cecconi M, Malesci A, Bonovas S, Danese S, Humanitas C-TF (2020) COVID-19 digestive system involvement and clinical outcomes in a large academic hospital in Milan, Italy. Clin Gastroenterol Hepatol 18 (10):2366-2368.e2363. 18(10):2366\u20132368.e3. https:\/\/doi.org\/10.1016\/j.cgh.2020.05.011","DOI":"10.1016\/j.cgh.2020.05.011"},{"issue":"3","key":"123_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","volume":"73","author":"Q Cai","year":"2020","unstructured":"Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, Li Z, Zhou G, Gou J, Qu J, Sun Y, Liu Y, He Q, Chen J, Liu L, Xu L (2020) COVID-19: abnormal liver function tests. J Hepatol 73(3):566\u2013574. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.006","journal-title":"J Hepatol"},{"issue":"10","key":"123_CR38","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1016\/j.cgh.2020.05.049","volume":"18","author":"S Ferm","year":"2020","unstructured":"Ferm S, Fisher C, Pakala T, Tong M, Shah D, Schwarzbaum D, Cooley V, Hussain S, Kim SH (2020) Analysis of gastrointestinal and hepatic manifestations of SARS-CoV-2 infection in 892 patients in Queens, NY. Clin Gastroenterol Hepatol 18(10):2378\u20132379.e2371. https:\/\/doi.org\/10.1016\/j.cgh.2020.05.049","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"123_CR39","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s12072-020-10071-9","volume":"14","author":"P Kumar-M","year":"2020","unstructured":"Kumar-M P, Mishra S, Jha DK, Shukla J, Choudhury A, Mohindra R, Mandavdhare HS, Dutta U, Sharma V (2020) Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis. Hepatol Int 14(5):711\u2013722. https:\/\/doi.org\/10.1007\/s12072-020-10071-9","journal-title":"Hepatol Int"},{"issue":"11","key":"123_CR40","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1007\/s11427-020-1733-4","volume":"63","author":"W Huang","year":"2020","unstructured":"Huang W, Li C, Wang Z, Wang H, Zhou N, Jiang J, Ni L, Zhang XA, Wang D-W (2020) Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases. Sci China Life Sci 63(11):1678\u20131687. https:\/\/doi.org\/10.1007\/s11427-020-1733-4","journal-title":"Sci China Life Sci"},{"issue":"6","key":"123_CR41","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.2214\/AJR.20.22954","volume":"214","author":"Y Li","year":"2020","unstructured":"Li Y, Xia L (2020) Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management. Am J Roentgenol 214(6):1280\u20131286. https:\/\/doi.org\/10.2214\/AJR.20.22954","journal-title":"Am J Roentgenol"},{"key":"123_CR42","doi-asserted-by":"publisher","first-page":"108961","DOI":"10.1016\/j.ejrad.2020.108961","volume":"126","author":"C Long","year":"2020","unstructured":"Long C, Xu H, Shen Q, Zhang X, Fan B, Wang C, Zeng B, Li Z, Li X, Li H (2020) Diagnosis of the coronavirus disease (COVID-19): rRT-PCR or CT? Eur J Radiol 126:108961\u2013108961. https:\/\/doi.org\/10.1016\/j.ejrad.2020.108961","journal-title":"Eur J Radiol"},{"issue":"5","key":"123_CR43","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1007\/s00330-020-07347-x","volume":"31","author":"A Kov\u00e1cs","year":"2021","unstructured":"Kov\u00e1cs A, Pal\u00e1sti P, Ver\u00e9b D, Bozsik B, Palk\u00f3 A, Kincses ZT (2021) The sensitivity and specificity of chest CT in the diagnosis of COVID-19. Eur Radiol 31(5):2819\u20132824. https:\/\/doi.org\/10.1007\/s00330-020-07347-x","journal-title":"Eur Radiol"},{"issue":"1","key":"123_CR44","doi-asserted-by":"publisher","first-page":"E207","DOI":"10.1148\/radiol.2020201908","volume":"297","author":"R Bhayana","year":"2020","unstructured":"Bhayana R, Som A, Li MD, Carey DE, Anderson MA, Blake MA, Catalano O, Gee MS, Hahn PF, Harisinghani M, Kilcoyne A, Lee SI, Mojtahed A, Pandharipande PV, Pierce TT, Rosman DA, Saini S, Samir AE, Simeone JF, Gervais DA, Velmahos G, Misdraji J, Kambadakone A (2020) Abdominal imaging findings in COVID-19: preliminary observations. Radiology 297(1):E207\u2013E215. https:\/\/doi.org\/10.1148\/radiol.2020201908","journal-title":"Radiology"},{"key":"123_CR45","doi-asserted-by":"publisher","first-page":"e926785","DOI":"10.12659\/AJCR.926785","volume":"21","author":"SK Thuluva","year":"2020","unstructured":"Thuluva SK, Zhu H, Tan MML, Gupta S, Yeong KY, Cheong Wah ST, Lin L, Yap ES (2020) A 29-year-old male construction worker from India who presented with left-sided abdominal pain due to isolated superior mesenteric vein thrombosis associated with SARS-CoV-2 infection. Am J Case Rep 21:e926785. https:\/\/doi.org\/10.12659\/AJCR.926785","journal-title":"Am J Case Rep"},{"issue":"4","key":"123_CR46","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.4269\/ajtmh.20-0894","volume":"103","author":"YS Ibrahim","year":"2020","unstructured":"Ibrahim YS, Karuppasamy G, Parambil JV, Alsoub H, Al-Shokri SD (2020) Case Report: Paralytic ileus: a potential extrapulmonary manifestation of severe COVID-19. Am J Trop Med Hyg 103(4):1600\u20131603. https:\/\/doi.org\/10.4269\/ajtmh.20-0894","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"123_CR47","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1097\/PEC.0000000000002155","volume":"36","author":"I Mart\u00ednez-Casta\u00f1o","year":"2020","unstructured":"Mart\u00ednez-Casta\u00f1o I, Calabuig-Barbero E, Gonz\u00e1lvez-Pi\u00f1era J, L\u00f3pez-Ayala JM (2020) COVID-19 infection is a diagnostic challenge in infants with ileocecal intussusception. Pediatr Emerg Care 36(6):e368. https:\/\/doi.org\/10.1097\/PEC.0000000000002155","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"123_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000445","volume":"7","author":"M Effenberger","year":"2020","unstructured":"Effenberger M, Grander C, Fritsche G, Bellmann-Weiler R, Hartig F, Wildner S, Seiwald S, Adolph TE, Zoller H, Weiss G, Tilg H (2020) Liver stiffness by transient elastography accompanies illness severity in COVID-19. BMJ Open Gastroenterology 7(1):e000445. https:\/\/doi.org\/10.1136\/bmjgast-2020-000445","journal-title":"BMJ Open Gastroenterology"},{"key":"123_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijid.2020.04.027","volume":"96","author":"H Zhang","year":"2020","unstructured":"Zhang H, Li HB, Lyu JR, Lei XM, Li W, Wu G, Lyu J, Dai ZM (2020) Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 96:19\u201324. https:\/\/doi.org\/10.1016\/j.ijid.2020.04.027","journal-title":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases"},{"issue":"1","key":"123_CR50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.surg.2020.04.035","volume":"168","author":"M Ignat","year":"2020","unstructured":"Ignat M, Philouze G, Aussenac-Belle L, Faucher V, Collange O, Mutter D, Pessaux P (2020) Small bowel ischemia and SARS-CoV-2 infection: an underdiagnosed distinct clinical entity. Surgery 168(1):14\u201316. https:\/\/doi.org\/10.1016\/j.surg.2020.04.035","journal-title":"Surgery"},{"issue":"1","key":"123_CR51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jmv.26119","volume":"93","author":"S Carnevale","year":"2020","unstructured":"Carnevale S, Beretta P, Morbini P (2020) Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of COVID-19 patient with diarrhea. J Med Virol 93(1):61\u201363. https:\/\/doi.org\/10.1002\/jmv.26119","journal-title":"J Med Virol"},{"issue":"11","key":"123_CR52","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s00134-020-06237-6","volume":"46","author":"K Stahl","year":"2020","unstructured":"Stahl K, Br\u00e4sen JH, Hoeper MM, David S (2020) Direct evidence of SARS-CoV-2 in gut endothelium. Intensive Care Med 46(11):2081\u20132082. https:\/\/doi.org\/10.1007\/s00134-020-06237-6","journal-title":"Intensive Care Med"},{"issue":"6","key":"123_CR53","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41379-020-0536-x","volume":"33","author":"S Tian","year":"2020","unstructured":"Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, Xiao S-Y (2020) Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol 33(6):1007\u20131014. https:\/\/doi.org\/10.1038\/s41379-020-0536-x","journal-title":"Mod Pathol"},{"issue":"9","key":"123_CR54","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1111\/liv.14601","volume":"40","author":"A Sonzogni","year":"2020","unstructured":"Sonzogni A, Previtali G, Seghezzi M, Grazia Alessio M, Gianatti A, Licini L, Morotti D, Zerbi P, Carsana L, Rossi R, Lauri E, Pellegrinelli A, Nebuloni M (2020) Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations. Liver Int 40(9):2110\u20132116 https:\/\/doi.org\/10.1111\/liv.14601","journal-title":"Liver Int"},{"issue":"11","key":"123_CR55","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/s41379-020-00649-x","volume":"33","author":"SM Lagana","year":"2020","unstructured":"Lagana SM, Kudose S, Iuga AC, Lee MJ, Fazlollahi L, Remotti HE, Del Portillo A, De Michele S, de Gonzalez AK, Saqi A, Khairallah P, Chong AM, Park H, Uhlemann A-C, Lefkowitch JH, Verna EC (2020) Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data. Mod Pathol 33(11):2147\u20132155. https:\/\/doi.org\/10.1038\/s41379-020-00649-x","journal-title":"Mod Pathol"},{"issue":"3","key":"123_CR56","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jcmgh.2020.09.015","volume":"11","author":"MI Fiel","year":"2020","unstructured":"Fiel MI, El Jamal SM, Paniz-Mondolfi A, Gordon RE, Reidy J, Bandovic J, Advani R, Kilaru S, Pourmand K, Ward S, Thung SN, Schiano T (2020) Findings of severe hepatic severe acute respiratory syndrome coronavirus-2 infection. Cell Mol Gastroenterol Hepatol 11(3):763\u2013770. https:\/\/doi.org\/10.1016\/j.jcmgh.2020.09.015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"10","key":"123_CR57","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.14309\/ajg.0000000000000798","volume":"115","author":"CV Almario","year":"2020","unstructured":"Almario CV, Chey WD, Spiegel BMR (2020) Increased risk of COVID-19 among users of proton pump inhibitors. Am J Gastroenterol 115(10):1707\u20131715. https:\/\/doi.org\/10.14309\/ajg.0000000000000798","journal-title":"Am J Gastroenterol"},{"issue":"19","key":"123_CR58","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.3748\/wjg.v26.i19.2286","volume":"26","author":"J Wu","year":"2020","unstructured":"Wu J, Song S, Cao H-C, Li L-J (2020) Liver diseases in COVID-19: etiology, treatment and prognosis. World J Gastroenterol 26(19):2286\u20132293. https:\/\/doi.org\/10.3748\/wjg.v26.i19.2286","journal-title":"World J Gastroenterol"},{"issue":"1","key":"123_CR59","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1053\/j.gastro.2020.04.012","volume":"159","author":"DT Rubin","year":"2020","unstructured":"Rubin DT, Feuerstein JD, Wang AY, Cohen RD (2020) AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary. Gastroenterology 159(1):350\u2013357. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.012","journal-title":"Gastroenterology"},{"issue":"2","key":"123_CR60","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","volume":"159","author":"EJ Brenner","year":"2020","unstructured":"Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier J-F, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel J-F, Kappelman MD (2020) Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology 159(2):481\u2013491.e3. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.032","journal-title":"Gastroenterology"},{"issue":"3","key":"123_CR61","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/0897190019894428","volume":"34","author":"CA Ellison","year":"2020","unstructured":"Ellison CA, Blackwell SB (2020) Acute hepatocellular injury associated with azithromycin. J Pharm Pract 34(3):493\u2013496. https:\/\/doi.org\/10.1177\/0897190019894428","journal-title":"J Pharm Pract"},{"issue":"4","key":"123_CR62","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gut.35.4.569","volume":"35","author":"AJ Makin","year":"1994","unstructured":"Makin AJ, Wendon J, Fitt S, Portmann BC, Williams R (1994) Fulminant hepatic failure secondary to hydroxychloroquine. Gut 35(4):569\u2013570. https:\/\/doi.org\/10.1136\/gut.35.4.569","journal-title":"Gut"},{"issue":"1","key":"123_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","volume":"6","author":"J Liu","year":"2020","unstructured":"Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H, Li Y, Hu Z, Zhong W, Wang M (2020) Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discovery 6(1):16. https:\/\/doi.org\/10.1038\/s41421-020-0156-0","journal-title":"Cell Discovery"},{"issue":"10223","key":"123_CR64","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"issue":"8","key":"123_CR65","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S2468-1253(20)30190-4","volume":"5","author":"GL-H Wong","year":"2020","unstructured":"Wong GL-H, Wong VW-S, Thompson A, Jia J, Hou J, Lesmana CRA, Susilo A, Tanaka Y, Chan W-K, Gane E, Ong-Go AK, Lim S-G, Ahn SH, Yu M-L, Piratvisuth T, Chan HL-Y (2020) Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. The Lancet Gastroenterology & Hepatology 5(8):776\u2013787. https:\/\/doi.org\/10.1016\/S2468-1253(20)30190-4","journal-title":"The Lancet Gastroenterology & Hepatology"},{"issue":"3","key":"123_CR66","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.clinre.2020.04.001","volume":"44","author":"N Ganne-Carri\u00e9","year":"2020","unstructured":"Ganne-Carri\u00e9 N, Fontaine H, Dumortier J, Boursier J, Bureau C, Leroy V, Bourli\u00e8re M, Afef FAftSotL (2020) Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic. Clin Res Hepatol Gastroenterol 44(3):275\u2013281. https:\/\/doi.org\/10.1016\/j.clinre.2020.04.001","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"123_CR67","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/jgh3.12456","volume":"5","author":"RD Dorrell","year":"2020","unstructured":"Dorrell RD, Dougherty MK, Barash EL, Lichtig AE, Clayton SB, Jensen ET (2020) Gastrointestinal and hepatic manifestations of COVID-19: a systematic review and meta-analysis. JGH Open 5(1):107\u2013115. https:\/\/doi.org\/10.1002\/jgh3.12456","journal-title":"JGH Open"},{"key":"123_CR68","doi-asserted-by":"publisher","first-page":"579415","DOI":"10.3389\/fphar.2020.579415","volume":"11","author":"H Abdelzaher","year":"2020","unstructured":"Abdelzaher H, Saleh BM, Ismail HA, Hafiz M, Gabal MA, Mahmoud M, Hashish S, Gawad RMA, Gharieb RY, Abdelnaser A (2020) COVID-19 genetic and environmental risk factors: a look at the evidence. Front Pharmacol 11:579415\u2013579415. https:\/\/doi.org\/10.3389\/fphar.2020.579415","journal-title":"Front Pharmacol"},{"issue":"7","key":"123_CR69","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S2468-1253(20)30126-6","volume":"5","author":"R Mao","year":"2020","unstructured":"Mao R, Qiu Y, He J-S, Tan J-Y, Li X-H, Liang J, Shen J, Zhu L-R, Chen Y, Iacucci M, Ng SC, Ghosh S, Chen M-H (2020) Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 5(7):667\u2013678. https:\/\/doi.org\/10.1016\/S2468-1253(20)30126-6","journal-title":"The Lancet Gastroenterology & Hepatology"},{"issue":"5","key":"123_CR70","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/archdischild-2020-320338","volume":"106","author":"P Zimmermann","year":"2020","unstructured":"Zimmermann P, Curtis N (2020) Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child 106(5):429\u2013439. https:\/\/doi.org\/10.1136\/archdischild-2020-320338","journal-title":"Arch Dis Child"},{"issue":"8","key":"123_CR71","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1053\/j.gastro.2020.03.020","volume":"158","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Zhao N, Shu Y, Han S, Chen B, Shu X (2020) Effect of gastrointestinal symptoms in patients with COVID-19. Gastroenterology 158(8):2294\u20132297. https:\/\/doi.org\/10.1053\/j.gastro.2020.03.020","journal-title":"Gastroenterology"},{"issue":"1","key":"123_CR72","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12015-020-10048-z","volume":"17","author":"H Agrawal","year":"2020","unstructured":"Agrawal H, Das N, Nathani S, Saha S, Saini S, Kakar SS, Roy P (2020) An assessment on impact of COVID-19 infection in a gender specific manner. Stem Cell Rev Rep 17(1):94\u2013112. https:\/\/doi.org\/10.1007\/s12015-020-10048-z","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"123_CR73","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1053\/j.gastro.2020.05.010","volume":"159","author":"K Hajifathalian","year":"2020","unstructured":"Hajifathalian K, Krisko T, Mehta A, Kumar S, Schwartz R, Fortune B, Sharaiha RZ, group\u2217 W-Gr (2020) Gastrointestinal and hepatic manifestations of 2019 novel coronavirus disease in a large cohort of infected patients from New York: clinical implications. Gastroenterology 159(3):1137\u20131140.e1132. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.010","journal-title":"Gastroenterology"},{"key":"123_CR74","doi-asserted-by":"publisher","first-page":"608259","DOI":"10.3389\/fmed.2020.608259","volume":"7","author":"R Chen","year":"2020","unstructured":"Chen R, Yu Y-L, Li W, Liu Y, Lu J-X, Chen F, Zhou Q, Xia Z-Y, Gao L, Meng Q-T, Ma D (2020) Gastrointestinal symptoms associated with unfavorable prognosis of COVID-19 patients: a retrospective study. Front Med (Lausanne) 7:608259\u2013608259. https:\/\/doi.org\/10.3389\/fmed.2020.608259","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"123_CR75","doi-asserted-by":"publisher","first-page":"102639","DOI":"10.1016\/j.autrev.2020.102639","volume":"19","author":"F Zingone","year":"2020","unstructured":"Zingone F, D'Odorico A, Lorenzon G, Marsilio I, Farinati F, Savarino EV (2020) Risk of COVID-19 in celiac disease patients. Autoimmun Rev 19(10):102639\u2013102639. https:\/\/doi.org\/10.1016\/j.autrev.2020.102639","journal-title":"Autoimmun Rev"},{"issue":"5","key":"123_CR76","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2020.06.001","volume":"73","author":"M Iavarone","year":"2020","unstructured":"Iavarone M, D'Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, Perricone G, Massironi S, Spinetti A, Buscarini E, Vigan\u00f2 M, Carriero C, Fagiuoli S, Aghemo A, Belli LS, Luc\u00e0 M, Pedaci M, Rimondi A, Rumi MG, Invernizzi P, Bonfanti P, Lampertico P (2020) High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol 73(5):1063\u20131071. https:\/\/doi.org\/10.1016\/j.jhep.2020.06.001","journal-title":"J Hepatol"},{"issue":"2","key":"123_CR77","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jhep.2020.03.044","volume":"73","author":"D Ji","year":"2020","unstructured":"Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y, Lau G (2020) Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. J Hepatol 73(2):451\u2013453. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.044","journal-title":"J Hepatol"},{"issue":"11","key":"123_CR78","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/hepr.13553","volume":"50","author":"J Liu","year":"2020","unstructured":"Liu J, Wang T, Cai Q, Sun L, Huang D, Zhou G, He Q, Wang F-S, Liu L, Chen J (2020) Longitudinal changes of liver function and hepatitis B reactivation in COVID-19 patients with pre-existing chronic hepatitis B virus infection. Hepatol Res 50(11):1211\u20131221. https:\/\/doi.org\/10.1111\/hepr.13553","journal-title":"Hepatol Res"},{"issue":"2","key":"123_CR79","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1053\/j.gastro.2020.04.064","volume":"159","author":"S Singh","year":"2020","unstructured":"Singh S, Khan A (2020) Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: a multicenter research network study. Gastroenterology 159(2):768\u2013771.e3. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.064","journal-title":"Gastroenterology"},{"issue":"7408","key":"123_CR80","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature11228","volume":"487","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, Sigl V, Hanada T, Hanada R, Lipinski S, Wild B, Camargo SMR, Singer D, Richter A, Kuba K, Fukamizu A, Schreiber S, Clevers H, Verrey F, Rosenstiel P, Penninger JM (2012) ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487(7408):477\u2013481. https:\/\/doi.org\/10.1038\/nature11228","journal-title":"Nature"},{"issue":"3","key":"123_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s43440-020-00195-y","volume":"73","author":"H Kaur","year":"2021","unstructured":"Kaur H, Shekhar N, Sharma S, Sarma P, Prakash A, Medhi B (2021) Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes. Pharmacol Rep 73(3):1\u201314. https:\/\/doi.org\/10.1007\/s43440-020-00195-y","journal-title":"Pharmacol Rep"},{"issue":"8","key":"123_CR82","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1086\/428839","volume":"40","author":"LM Fox","year":"2005","unstructured":"Fox LM, Saravolatz LD (2005) Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 40(8):1173\u20131180. https:\/\/doi.org\/10.1086\/428839","journal-title":"Clin Infect Dis"},{"issue":"1","key":"123_CR83","doi-asserted-by":"publisher","first-page":"21508","DOI":"10.1038\/s41598-020-78697-1","volume":"10","author":"\u0130 Ayg\u00fcn","year":"2020","unstructured":"Ayg\u00fcn \u0130, Kaya M, Alhajj R (2020) Identifying side effects of commonly used drugs in the treatment of Covid 19. Sci Rep 10(1):21508. https:\/\/doi.org\/10.1038\/s41598-020-78697-1","journal-title":"Sci Rep"},{"issue":"2","key":"123_CR84","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/cpt.1844","volume":"108","author":"Y-X Du","year":"2020","unstructured":"Du Y-X, Chen X-P (2020) Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection. Clinical Pharmacology & Therapeutics 108(2):242\u2013247 https:\/\/doi.org\/10.1002\/cpt.1844","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"1","key":"123_CR85","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/hep.1840170113","volume":"17","author":"H Okuno","year":"1993","unstructured":"Okuno H, Takasu M, Kano H, Seki T, Shiozaki Y, Inoue K (1993) Depression of drug-metabolizing activity in the human liver by interferon-\u03b2. Hepatology (Baltimore, Md) 17(1):65\u201369 https:\/\/doi.org\/10.1002\/hep.1840170113","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"10259","key":"123_CR86","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(20)32013-4","volume":"396","author":"PW Horby","year":"2020","unstructured":"Horby PW, Mafham M, Bell JL, Linsell L, Staplin N, Emberson J, Palfreeman A, Raw J, Elmahi E, Prudon B, Green C, Carley S, Chadwick D, Davies M, Wise MP, Baillie JK, Chappell LC, Faust SN, Jaki T, Jefferey K, Lim WS, Montgomery A, Rowan K, Juszczak E, Haynes R, Landray MJ (2020) Lopinavir\u2013ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 396(10259):1345\u20131352. https:\/\/doi.org\/10.1016\/S0140-6736(20)32013-4","journal-title":"Lancet"},{"issue":"3","key":"123_CR87","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30(3):269\u2013271. https:\/\/doi.org\/10.1038\/s41422-020-0282-0","journal-title":"Cell Res"},{"issue":"3","key":"123_CR88","doi-asserted-by":"publisher","first-page":"106114","DOI":"10.1016\/j.ijantimicag.2020.106114","volume":"56","author":"S Tong","year":"2020","unstructured":"Tong S, Su Y, Yu Y, Wu C, Chen J, Wang S, Jiang J (2020) Ribavirin therapy for severe COVID-19: a retrospective cohort study. Int J Antimicrob Agents 56(3):106114\u2013106114. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106114","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"123_CR89","doi-asserted-by":"publisher","first-page":"e586","DOI":"10.1016\/S2665-9913(20)30273-3","volume":"2","author":"NA Khan","year":"2020","unstructured":"Khan NA (2020) Anakinra for severe forms of COVID-19. The Lancet Rheumatology 2(10):e586\u2013e587. https:\/\/doi.org\/10.1016\/S2665-9913(20)30273-3","journal-title":"The Lancet Rheumatology"},{"issue":"10223","key":"123_CR90","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","volume":"395","author":"P Richardson","year":"2020","unstructured":"Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Rawling M, Savory E, Stebbing J (2020) Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet 395(10223):e30\u2013e31. https:\/\/doi.org\/10.1016\/S0140-6736(20)30304-4","journal-title":"Lancet"},{"issue":"3","key":"123_CR91","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000510770","volume":"144","author":"F La Ros\u00e9e","year":"2020","unstructured":"La Ros\u00e9e F, La Ros\u00e9e P (2020) Ruxolitinib in COVID-19 hyperinflammation and haematologic malignancies. Acta Haematol 144(3):246\u2013249. https:\/\/doi.org\/10.1159\/000510770","journal-title":"Acta Haematol"},{"issue":"5","key":"123_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14712598.2021.1847269","volume":"21","author":"S Khiali","year":"2020","unstructured":"Khiali S, Rezagholizadeh A, Entezari-Maleki T (2020) A comprehensive review on sarilumab in COVID-19. Expert Opin Biol Ther 21(5):1\u201312. https:\/\/doi.org\/10.1080\/14712598.2021.1847269","journal-title":"Expert Opin Biol Ther"},{"issue":"7","key":"123_CR93","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/1756-185X.13010","volume":"20","author":"L-F Chen","year":"2017","unstructured":"Chen L-F, Mo Y-Q, Jing J, Ma J-D, Zheng D-H, Dai L (2017) Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation. Int J Rheum Dis 20(7):859\u2013869 https:\/\/doi.org\/10.1111\/1756-185X.13010","journal-title":"Int J Rheum Dis"}],"container-title":["Egyptian Liver Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43066-021-00123-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43066-021-00123-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43066-021-00123-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T19:02:48Z","timestamp":1627758168000},"score":1,"resource":{"primary":{"URL":"https:\/\/eglj.springeropen.com\/articles\/10.1186\/s43066-021-00123-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,31]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["123"],"URL":"https:\/\/doi.org\/10.1186\/s43066-021-00123-6","relation":{},"ISSN":["2090-6226"],"issn-type":[{"type":"electronic","value":"2090-6226"}],"subject":[],"published":{"date-parts":[[2021,7,31]]},"assertion":[{"value":"24 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}